法国大巴黎地区新冠疫情期间被拒绝接受体外膜肺氧合治疗的患者的结局 - Suppr

Outcomes of Patients Denied Extracorporeal Membrane Oxygenation during the COVID-19 Pandemic in Greater Paris, France.

作者信息

Levy David, Lebreton Guillaume, Pineton de Chambrun Marc, Hékimian Guillaume, Chommeloux Juliette, Bréchot Nicolas, Luyt Charles-Edouard, Leprince Pascal, Combes Alain, Schmidt Matthieu

机构信息

Sorbonne Université Paris, France.

Hôpital Pitié-Salpêtrière Paris, France.

出版信息

Am J Respir Crit Care Med. 2021 Oct 15;204(8):994-997. doi: 10.1164/rccm.202105-1312LE.

DOI:10.1164/rccm.202105-1312LE

PMID:34375170

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8534624/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763e/8534624/020f447d0fde/rccm.202105-1312LEf1.jpg

相似文献

Outcomes of Patients Denied Extracorporeal Membrane Oxygenation during the COVID-19 Pandemic in Greater Paris, France.法国大巴黎地区新冠疫情期间被拒绝接受体外膜肺氧合治疗的患者的结局

Am J Respir Crit Care Med. 2021 Oct 15;204(8):994-997. doi: 10.1164/rccm.202105-1312LE.

Organization of extracorporeal membrane oxygenation services for COVID-19.COVID-19 体外膜肺氧合服务的组织。

Asian Cardiovasc Thorac Ann. 2021 Mar;29(3):165-169. doi: 10.1177/0218492320962932. Epub 2020 Sep 30.

Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris.巴黎索邦大学医院严重 COVID-19 急性呼吸窘迫综合征体外膜肺氧合支持的治疗结果演变。

Crit Care. 2021 Oct 9;25(1):355. doi: 10.1186/s13054-021-03780-6.

Extracorporeal Membrane Oxygenation instead of Invasive Mechanical Ventilation in a Patient with Severe COVID-19-associated Acute Respiratory Distress Syndrome.体外膜肺氧合替代有创机械通气用于一名患有严重新型冠状病毒肺炎相关急性呼吸窘迫综合征的患者

Am J Respir Crit Care Med. 2021 Jun 15;203(12):1571-1573. doi: 10.1164/rccm.202102-0259LE.

Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study.体外膜肺氧合治疗 COVID-19 相关严重急性呼吸窘迫综合征的回顾性队列研究。

Lancet Respir Med. 2020 Nov;8(11):1121-1131. doi: 10.1016/S2213-2600(20)30328-3. Epub 2020 Aug 13.

Contrast Echocardiography in VV-ECMO-Dependent Patients with COVID-19.新冠病毒病依赖静脉-静脉体外膜肺氧合患者的对比超声心动图

J Am Soc Echocardiogr. 2020 Nov;33(11):1419-1420. doi: 10.1016/j.echo.2020.07.012. Epub 2020 Jul 17.

High In-Hospital Mortality Rate in Patients with COVID-19 Receiving Extracorporeal Membrane Oxygenation in Germany: A Critical Analysis.德国接受体外膜肺氧合治疗的新冠病毒疾病患者的院内死亡率较高：一项批判性分析。

Am J Respir Crit Care Med. 2021 Oct 15;204(8):991-994. doi: 10.1164/rccm.202105-1145LE.

Serratia marcescens outbreak in the intensive care unit during the COVID-19 pandemic: A paradoxical risk?新型冠状病毒肺炎大流行期间重症监护病房的粘质沙雷氏菌暴发：一种矛盾的风险？

Med Mal Infect. 2020 Nov;50(8):750-751. doi: 10.1016/j.medmal.2020.05.004. Epub 2020 May 21.

Clinical and biochemical characteristics of patients admitted to ICU with SARS-CoV-2.新型冠状病毒肺炎（SARS-CoV-2）重症监护病房（ICU）收治患者的临床和生化特征

Med Intensiva (Engl Ed). 2020 Dec;44(9):589-590. doi: 10.1016/j.medin.2020.05.003. Epub 2020 May 16.

COVID-19: How the Paris area faced the massive influx of critical patients.新冠疫情：巴黎地区如何应对危重症患者的大量涌入。

Anaesth Crit Care Pain Med. 2020 Oct;39(5):575-576. doi: 10.1016/j.accpm.2020.07.009. Epub 2020 Jul 11.

引用本文的文献

Outcomes and risk factors of transported patients with extracorporeal membrane oxygenation: An ECMO center experience.体外膜肺氧合转运患者的结局及危险因素：一家体外膜肺氧合中心的经验

J Intensive Med. 2024 Jun 14;5(1):35-42. doi: 10.1016/j.jointm.2024.04.003. eCollection 2025 Jan.

Lung Transplant Success in COVID-19 Patients Requiring V-V ECMO: One-Year Follow-Up.需要静脉-静脉体外膜肺氧合的新冠肺炎患者肺移植成功：一年随访

Ann Transplant. 2024 Dec 24;29:e946088. doi: 10.12659/AOT.946088.

Extracorporeal membrane oxygenation: unmet needs and perspectives.体外膜肺氧合：未满足的需求与展望

Rheumatol Int. 2024 Dec;44(12):2745-2756. doi: 10.1007/s00296-024-05732-z. Epub 2024 Oct 16.

Use of Extracorporeal Membrane Oxygenation for Patients with Coronavirus Disease 2019 Infection.体外膜肺氧合在新型冠状病毒感染患者中的应用。

Adv Surg. 2024 Sep;58(1):249-273. doi: 10.1016/j.yasu.2024.05.003. Epub 2024 Jun 29.

Outcomes of Severe ARDS COVID-19 Patients Denied for Venovenous ECMO Support: A Prospective Observational Comparative Study.被拒绝接受静脉-静脉体外膜肺氧合支持的重症新型冠状病毒肺炎急性呼吸窘迫综合征患者的结局：一项前瞻性观察性比较研究

J Clin Med. 2024 Mar 5;13(5):1493. doi: 10.3390/jcm13051493.

COVID-19 Is an Independent Risk Factor for Detrimental Invasive Fungal Disease in Patients on Veno-Venous Extracorporeal Membrane Oxygenation: A Retrospective Study.COVID-19是接受静脉-静脉体外膜肺氧合治疗患者发生侵袭性真菌病的独立危险因素：一项回顾性研究。

J Fungi (Basel). 2023 Jul 15;9(7):751. doi: 10.3390/jof9070751.

Transfer of Veno-venous Extracorporeal Membrane Oxygenation Patients With COVID-19 Associated Acute Respiratory Distress Syndrome.COVID-19 相关急性呼吸窘迫综合征行体外膜肺氧合的患者的静脉-静脉转流。

ASAIO J. 2023 Aug 1;69(8):789-794. doi: 10.1097/MAT.0000000000001954. Epub 2023 May 5.

The Use of Extracorporeal Membrane Oxygenation for COVID-19: Lessons Learned.体外膜肺氧合在 COVID-19 中的应用：经验教训。

Clin Chest Med. 2023 Jun;44(2):335-346. doi: 10.1016/j.ccm.2022.11.016. Epub 2022 Nov 29.

Multi-horizon predictive models for guiding extracorporeal resource allocation in critically ill COVID-19 patients.多时间尺度预测模型指导 COVID-19 危重症患者体外资源配置。

J Am Med Inform Assoc. 2023 Mar 16;30(4):656-667. doi: 10.1093/jamia/ocac256.

Breathing pattern, accessory respiratory muscles work, and gas exchange evaluation for prediction of NIV failure in moderate-to-severe COVID-19-associated ARDS after deterioration of respiratory failure outside ICU: the COVID-NIV observational study.呼吸模式、辅助呼吸肌做功和气体交换评估对 ICU 外呼吸衰竭恶化后中重度 COVID-19 相关 ARDS 患者行 NIV 治疗失败的预测作用：COVID-NIV 观察性研究。

BMC Anesthesiol. 2022 Oct 1;22(1):307. doi: 10.1186/s12871-022-01847-7.

本文引用的文献

Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study.体外膜肺氧合网络组织与 COVID-19 大流行期间法国大巴黎地区的临床结局：一项多中心队列研究。

Lancet Respir Med. 2021 Aug;9(8):851-862. doi: 10.1016/S2213-2600(21)00096-5. Epub 2021 Apr 19.

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.托珠单抗治疗重症 COVID-19 肺炎住院患者。

N Engl J Med. 2021 Apr 22;384(16):1503-1516. doi: 10.1056/NEJMoa2028700. Epub 2021 Feb 25.

Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.4244 例危重症 COVID-19 成年患者的临床特征和第 90 天结局：一项前瞻性队列研究。

Intensive Care Med. 2021 Jan;47(1):60-73. doi: 10.1007/s00134-020-06294-x. Epub 2020 Oct 29.

Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry.COVID-19 患者的体外膜肺氧合支持：体外生命支持组织登记处的国际队列研究。

Lancet. 2020 Oct 10;396(10257):1071-1078. doi: 10.1016/S0140-6736(20)32008-0. Epub 2020 Sep 25.

Lancet Respir Med. 2020 Nov;8(11):1121-1131. doi: 10.1016/S2213-2600(20)30328-3. Epub 2020 Aug 13.

Saying no until the moment is right: initiating ECMO in the EOLIA era.直到时机合适才说“不”：在EOLIA时代启动体外膜肺氧合

Intensive Care Med. 2020 Oct;46(10):1894-1896. doi: 10.1007/s00134-020-06185-1. Epub 2020 Jul 31.

Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。

N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.

Remdesivir for the Treatment of Covid-19 - Final Report.瑞德西韦治疗 COVID-19 的疗效 - 最终报告。

N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.

Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.COVID-19 大流行期间和其他新发传染病疫情中严重急性呼吸窘迫综合征的体外膜肺氧合服务规划和供应。

Lancet Respir Med. 2020 May;8(5):518-526. doi: 10.1016/S2213-2600(20)30121-1. Epub 2020 Mar 20.

Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome.体外膜肺氧合治疗严重急性呼吸窘迫综合征。

N Engl J Med. 2018 May 24;378(21):1965-1975. doi: 10.1056/NEJMoa1800385.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Outcomes of Patients Denied Extracorporeal Membrane Oxygenation during the COVID-19 Pandemic in Greater Paris, France.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献